Hypertensive reactions associated with paclitaxel

Cancer Investigation

Volumn 14, Issue 4, 1996, Pages 340-342

  Solimando Jr , Dominic A ^a,c   Phillips, Evelyne T ^b   Weiss, Raymond B ^c   Dawson, Nancy A ^c   Diehl, Louis F ^c   Rickles, Nathaniel M ^b  

^a THOMAS JEFFERSON UNIVERSITY HOSPITAL   (United States)

^b CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

^c WALTER REED ARMY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PACLITAXEL;

AGED; ARTICLE; BLOOD PRESSURE MONITORING; BREAST CANCER; CASE REPORT; FEMALE; HUMAN; HYPERSENSITIVITY REACTION; HYPERTENSION; PATIENT MONITORING; PRIORITY JOURNAL;

EID: 8944242227     PISSN: 07357907     EISSN: None     Source Type: Journal    
DOI: 10.3109/07357909609012161     Document Type: Article

References (3)

1. Rowinsky EK, Eisenhauer EA, Chaudhry V, et al: Clinical toxicities encountered with paclitaxel (Taxol®). Semin Oncol 20(Suppl 3);1-15, 1993.
2. Kohler DR, Goldspiel BR. Paclitaxel (Taxol). Pharmacotherapy 14:3-34, 1994.
3. Bristol-Myers Squibb, Oncology Products Division, Paclitaxel (Taxol) package insert. Princeton, NJ, 1993.